• allarity therapeutics obtains clia certification for in-house drp testing and advances stenoparib toward fda registration marketscreener.com Tue, 07 Jul 2026 18:52:53 GMT
• Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration Yahoo Finance Tue, 07 Jul 2026 12:00:00 GMT
• allarity’s denmark lab gets clia status for u.s. cancer-trial testing Stock Titan Tue, 07 Jul 2026 12:00:00 GMT
• enterprise value to ebitda forward of allarity therapeutics, inc. – nasdaq:allr TradingView Wed, 01 Jul 2026 17:38:23 GMT
• Tranche Update on Allarity Therapeutics, Inc.'s Equity Buyback Plan announced on March 3, 2025. marketscreener.com Wed, 01 Jul 2026 15:40:59 GMT
• Allarity Therapeutics (NASDAQ: ALLR) wins key DRP patent and secures shareholder backing Stock Titan Wed, 01 Jul 2026 12:06:01 GMT
• Allarity Secures US Patent for Ovarian Cancer Companion Diagnostic Test Clinical Lab Products Tue, 30 Jun 2026 13:38:15 GMT
• Allarity receives U.S. patent for stenoparib diagnostic test By Investing.com Investing.com Nigeria Tue, 30 Jun 2026 12:23:17 GMT
• Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic Yahoo Finance Tue, 30 Jun 2026 12:00:00 GMT
• Price to earnings forward of Allarity Therapeutics, Inc. – NASDAQ:ALLR TradingView Tue, 30 Jun 2026 11:23:08 GMT
• enterprise value to ebit forward of allarity therapeutics, inc. – nasdaq:allr TradingView Tue, 30 Jun 2026 09:25:03 GMT
• Allarity wins U.S. patent protection for stenoparib test into 2042 Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• 4 ovarian cancer candidates to watch: GSK, Allarity and more BioSpace Mon, 29 Jun 2026 07:00:00 GMT
• Allarity Therapeutics, Inc. Actuals & Estimates (NASDAQ:ALLR) TradingView Fri, 26 Jun 2026 08:13:33 GMT
• is allarity therapeutics, inc. (allr) outperforming other medical stocks this year? MSN Wed, 24 Jun 2026 14:46:38 GMT
• allarity therapeutics inc (allr) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• 12 health care stocks moving in monday's after-market session Benzinga Mon, 22 Jun 2026 21:05:44 GMT
• allarity therapeutics showcases phase 2 stenoparib trial progress in advanced ovarian cancer at esmo 2026 Minichart Mon, 22 Jun 2026 17:25:00 GMT
• form 8k allarity therapeutics inc for: 22 june by investing.com Investing.com UK Mon, 22 Jun 2026 12:22:00 GMT
• Allarity Therapeutics (NASDAQ: ALLR) showcases Phase 2 stenoparib ovarian cancer trial Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year? Yahoo Finance Fri, 19 Jun 2026 07:00:00 GMT
• allarity to present trial-in-progress poster on phase 2 stenoparib trial TipRanks Thu, 18 Jun 2026 18:54:37 GMT
• allarity therapeutics inc (allr) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 11:24:51 GMT
• allarity therapeutics inc (allr) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 10:16:22 GMT
• allarity therapeutics inc (allr) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:41:36 GMT
• allarity therapeutics inc (allr) institutional confidence TradingKey Thu, 18 Jun 2026 07:18:11 GMT
• allarity therapeutics inc (allr) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 07:03:13 GMT
• Allarity takes Phase 2 ovarian cancer trial to ESMO Congress Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• allarity therapeutics to present trial-in-progress poster GlobeNewswire Thu, 18 Jun 2026 07:00:00 GMT
• allarity therapeutics inc (allr) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 06:45:12 GMT
• allarity therapeutics inc (allr) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 01:58:16 GMT
• allarity therapeutics inc (allr) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Thu, 18 Jun 2026 00:53:53 GMT
• allarity therapeutics inc (allr) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 00:48:36 GMT
• ALLR Q1 2026 Earnings: Narrower-Than-Expected Loss Amid Ongoing Clinical Development - Slow Growth Warning dars.gov.et Tue, 16 Jun 2026 07:00:00 GMT
• allarity therapeutics inc (allr) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• allarity therapeutics q1 2026 earnings: eps beat by 24.24% amid ongoing clinical development - earnings deceleration risk newsline.com Thu, 11 Jun 2026 22:37:01 GMT
• 12 Health Care Stocks Moving In Wednesday's After-Market Session Benzinga Wed, 10 Jun 2026 07:00:00 GMT
• allr q1 2026 earnings: narrower-than-expected loss highlights cost discipline - book value growth newsline.com Wed, 10 Jun 2026 00:35:23 GMT
• allr maintained by ascendiant capital -- price target raised to $10.25 GuruFocus Tue, 09 Jun 2026 01:30:00 GMT
• allr q1 2026 earnings: eps surprises to the upside as clinical advances continue - roa comparison dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• allarity therapeutics (allr) slides 5.3% as stock tests critical support level - volume climax dars.gov.et Sat, 06 Jun 2026 07:00:00 GMT
• allr q1 2026 earnings: eps beats estimates by 24% amid revenue absence and stock decline - healthcare earnings report newsline.com Fri, 05 Jun 2026 23:34:48 GMT
• Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year? Yahoo Finance Wed, 03 Jun 2026 07:00:00 GMT
• amended and restated management services agreement between allarity therapeutics, inc. and ljungaskog consulting ab effective june... Minichart Wed, 03 Jun 2026 07:00:00 GMT
• Allarity (NASDAQ: ALLR) updates CEO pay and severance terms Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• allarity therapeutics updates ceo management and compensation agreement TipRanks Tue, 02 Jun 2026 07:00:00 GMT
• number of shareholders of allarity therapeutics, inc. – nasdaq:allr TradingView Mon, 01 Jun 2026 23:30:54 GMT
• allr q1 2026 earnings: eps beat provides positive signal despite lack of revenue - profit recovery report The Legal Advocate Mon, 01 Jun 2026 04:46:44 GMT
• allr q1 2026 earnings: narrower loss surprises as pre-revenue biotech advances pipeline - guidance downgrade alert The Legal Advocate Mon, 01 Jun 2026 01:43:11 GMT
• ALLR Q1 2026 Earnings: Narrower Loss Surprises as Pre-Revenue Biotech Advances Pipeline - Dividend Growth Analysis dars.gov.et Sun, 31 May 2026 07:00:00 GMT
• allr q1 2026 earnings: eps beat provides positive signal despite lack of revenue - buyback announcement report newsline.com Sun, 31 May 2026 07:00:00 GMT
• allarity therapeutics (allr) faces selling pressure, holds above key support - risk parity rebalance newsline.com Fri, 29 May 2026 07:00:00 GMT
• allarity therapeutics (allr) hovers near support as mild pullback tests key levels - factor etf flow newsline.com Thu, 28 May 2026 07:00:00 GMT
• allarity therapeutics (allr) slides 4.8% in session; key support levels in focus - gex level newsline.com Tue, 26 May 2026 07:00:00 GMT
• allarity therapeutics (allr) surges 6.6% as volume picks up, testing key resistance - low risk entry stocks newsline.com Mon, 25 May 2026 07:00:00 GMT
• allarity (allr) posts q1 2026 earnings beat — here's what drove it - pre-announcement alert The Legal Advocate Thu, 21 May 2026 07:00:00 GMT
• allarity (allr) delivers q1 2026 beat — eps $-0.17 vs $-0.22 expected - earnings season preview The Legal Advocate Wed, 20 May 2026 07:00:00 GMT
• allarity therapeutics inc reports results for the quarter ended march 31 - earnings summary TradingView Fri, 15 May 2026 21:59:00 GMT
• allarity therapeutics, inc. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Fri, 15 May 2026 20:04:00 GMT
• Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers Yahoo Finance Fri, 15 May 2026 07:00:00 GMT
• allarity therapeutics advances stenoparib development for cancer treatments and strengthens financial position Quiver Quantitative Fri, 15 May 2026 07:00:00 GMT
• allarity therapeutics (allr) posts q1 2026 loss but lifts cash with $20m notes Stock Titan Fri, 15 May 2026 07:00:00 GMT
• u.s. va backs trial of allarity cancer drug for relapsed lung patients Stock Titan Fri, 15 May 2026 07:00:00 GMT
• allarity therapeutics reports first quarter 2026 financial results and stenoparib development update geneonline.com Fri, 15 May 2026 07:00:00 GMT
• why allarity (allr) just dropped -1.30% — what to watch 2026-05-14 - rsi oversold picks newsline.com Thu, 14 May 2026 07:00:00 GMT
• allarity therapeutics (allr) ceo receives 200,000-share rsu equity grant Stock Titan Thu, 14 May 2026 07:00:00 GMT
• director jesper hoeiland receives 25,000-share grant at allarity (allr) Stock Titan Mon, 11 May 2026 07:00:00 GMT
• director jesper hoeiland joins allarity therapeutics (allr) with initial form 3 filing Stock Titan Mon, 11 May 2026 07:00:00 GMT
• allarity therapeutics advances stenoparib, a dual parp and wnt inhibitor with drp® companion diagnostic, in phase 2 cancer trials Minichart Sat, 09 May 2026 07:00:00 GMT
• [8-k] allarity therapeutics, inc. reports material event Stock Titan Fri, 08 May 2026 21:20:21 GMT
• allarity therapeutics ceo thomas jensen to speak at precision medicine forum europe 2026 Quiver Quantitative Fri, 08 May 2026 12:51:00 GMT
• Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm GlobeNewswire Fri, 08 May 2026 07:00:00 GMT
• allarity ceo to outline cancer drug trial work at stockholm forum Stock Titan Fri, 08 May 2026 07:00:00 GMT
• allarity details stenoparib data, ceo to speak in europe | allr 8-k filing Stock Titan Fri, 08 May 2026 07:00:00 GMT
• allarity highlights stenoparib progress in new investor presentation TipRanks Fri, 08 May 2026 07:00:00 GMT
• director at allarity therapeutics (allr) receives 45,000 rsus in grant Stock Titan Thu, 07 May 2026 07:00:00 GMT
• ongoing deadline alert: faruqi & faruqi, llp investigates claims on behalf of investors of allarity therapeutics TMX Newsfile Thu, 07 May 2026 03:07:36 GMT
• stenoparib phase 3 manufacturing on track as allarity (nasdaq: allr) preps trials Stock Titan Wed, 06 May 2026 07:00:00 GMT
• allarity therapeutics advances stenoparib toward phase 3 and fda approval in ovarian cancer with manufacturing milestone Minichart Wed, 06 May 2026 07:00:00 GMT
• Allarity Therapeutics Advances Stenoparib Toward Pivotal Development with Phase 3 Manufacturing Campaign GlobeNewswire Tue, 05 May 2026 07:00:00 GMT
• allarity readies ovarian cancer drug with no more manufacturing cash due Stock Titan Tue, 05 May 2026 07:00:00 GMT
• allarity advances stenoparib manufacturing for pivotal trial Investing.com Tue, 05 May 2026 07:00:00 GMT
• what allarity (allr) is doing to earn customer loyalty (institutional demand) 2026-05-05 - sentiment divergence newsline.com Tue, 05 May 2026 07:00:00 GMT
• allarity advances stenoparib with phase 3 manufacturing, targeting fda approval for ovarian cancer. Pluang Tue, 05 May 2026 07:00:00 GMT
• equity grant gives allarity therapeutics (allr) officer 133,333 rsus Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• allarity therapeutics (allr) cfo awarded 150,000 restricted stock units Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• allarity therapeutics (nasdaq: allr) details 2026 votes on eloc, pay and equity plan Stock Titan Thu, 30 Apr 2026 07:00:00 GMT
• uspto allows allarity (nasdaq: allr) stenoparib drp patent with exclusivity to 2039 Stock Titan Tue, 28 Apr 2026 07:00:00 GMT
• Allarity Therapeutics Announces that the Stenoparib DRP® GlobeNewswire Mon, 27 Apr 2026 07:00:00 GMT
• allarity patent notice puts stenoparib companion test on path to 2039 Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• allarity receives uspto patent notice for stenoparib diagnostic Investing.com Mon, 27 Apr 2026 07:00:00 GMT
• 255,103 shares registered for resale by 3i, lp — allarity (nasdaq: allr) Stock Titan Mon, 27 Apr 2026 07:00:00 GMT
• allarity therapeutics (nasdaq: allr) updates auditor consent in s-3/a Stock Titan Fri, 24 Apr 2026 07:00:00 GMT
• allr (allarity therapeutics inc.) reports narrower q3 2025 loss than expected, but shares dip slightly in today’s trading. - earni... Xã Thanh Hà Thu, 23 Apr 2026 07:05:17 GMT
• allr (allarity therapeutics inc.) reports narrower q3 2025 loss than expected, but shares dip slightly in today’s trading. - earni... Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 19:05:16 GMT
• allarity therapeutics (nasdaq: allr) highlights new stenoparib and drp® data from aacr 2026 Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• allarity presents cancer drug data at aacr meeting by investing.com Investing.com Australia Wed, 22 Apr 2026 01:06:13 GMT
• allarity therapeutics presents two aacr 2026 posters highlighting stenoparib's potential in colorectal cancer as well as new predi... Investing News Network Tue, 21 Apr 2026 07:00:00 GMT
• colon cancer data and ovarian survival link lead allarity's aacr update Stock Titan Tue, 21 Apr 2026 07:00:00 GMT
• allarity (allr) stock enterprise value (drifts higher) 2026-04-20 - counter trend trade newsline.com Mon, 20 Apr 2026 07:00:00 GMT
• allr (allarity therapeutics inc.) reports narrower q3 2025 loss than expected, but shares dip slightly in today’s trading. - earni... newsline.com Sat, 18 Apr 2026 07:00:00 GMT
• aug reactions: will allarity therapeutics inc stock recover after earnings - portfolio risk summary & long-term growth portfolio p... baoquankhu1.vn Mon, 13 Apr 2026 17:08:46 GMT
• stock ratings | down 54%! morgan stanley lowered its price target for robinhood (hood) from $147 to $95; benchmark raised its pric... Sahm Mon, 13 Apr 2026 07:00:00 GMT
• smart money: is allarity therapeutics inc backed by strong institutional buying - market trend summary & real-time chart breakout ... baoquankhu1.vn Sun, 12 Apr 2026 10:57:50 GMT
• earnings miss: can allarity therapeutics inc weather a recession - ceo change & ai driven stock price forecasts baoquankhu1.vn Sat, 11 Apr 2026 20:28:45 GMT
• allr: ascendiant capital maintains buy rating, raises price targ GuruFocus Fri, 10 Apr 2026 10:37:03 GMT
• [pre 14a] allarity therapeutics, inc. preliminary proxy statement Stock Titan Fri, 10 Apr 2026 07:00:00 GMT
• allarity therapeutics, inc. (allr) stock price, news, quote and history Yahoo Finance UK Thu, 02 Apr 2026 20:00:00 GMT
• allarity therapeutics posts $320k revenue, $11.2m net loss and $14.7m year-end cash (2025) TradingView Wed, 01 Apr 2026 07:00:00 GMT
• allarity therapeutics (nasdaq: allr) cuts 2025 loss to $11.2m and posts first revenue Stock Titan Wed, 01 Apr 2026 07:00:00 GMT
• allarity therapeutics reports 2025 financial results, advances stenoparib in ovarian and lung cancer with fda fast track designati... Minichart Wed, 01 Apr 2026 07:00:00 GMT
• allr stock news today | earnings, events & price alerts Intellectia AI Wed, 01 Apr 2026 06:46:34 GMT
• allarity therapeutics, inc. (allr) stock price, news, quote & history Yahoo! Finance Canada Tue, 31 Mar 2026 23:42:22 GMT
• allr stock news today | earnings, events & price alerts Intellectia AI Tue, 31 Mar 2026 21:46:34 GMT
• allarity therapeutics, inc. (allr) reports fy2025 earnings AlphaStreet Tue, 31 Mar 2026 13:54:52 GMT
• market catalysts: is allarity therapeutics inc stock forming a cup and handle - weekly investment report & high accuracy trade sig... baoquankhu1.vn Tue, 31 Mar 2026 13:17:43 GMT
• Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress GlobeNewswire Tue, 31 Mar 2026 07:00:00 GMT
• cancer drug gets fda fast track as allarity says cash lasts to 2028 Stock Titan Tue, 31 Mar 2026 07:00:00 GMT
• stenoparib push: allarity therapeutics (nasdaq: allr) reshapes cancer pipeline Stock Titan Mon, 30 Mar 2026 21:29:20 GMT
• allarity therapeutics, inc. reports earnings results for the full year ended december 31, 2025 marketscreener.com Mon, 30 Mar 2026 21:29:00 GMT
• short interest in allarity therapeutics, inc. (nasdaq:allr) expands by 27.2% Defense World Mon, 30 Mar 2026 08:04:16 GMT
• tranche update on allarity therapeutics, inc.'s equity buyback plan announced on march 3, 2025. marketscreener.com Mon, 30 Mar 2026 07:00:00 GMT
• shorts report: can allarity therapeutics inc disrupt its industry - 2026 market trends & consistent return strategy ideas baoquankhu1.vn Sat, 28 Mar 2026 12:18:07 GMT
• Former Allarity Executive Winnows SEC’s FDA Approval Scheme Suit Bloomberg Law News Wed, 25 Mar 2026 07:00:00 GMT
• allarity therapeutics (allr) projected to post quarterly earnings on monday Defense World Mon, 23 Mar 2026 06:17:01 GMT
• volume summary: will allarity therapeutics inc stock recover after earnings - dip buying & safe entry trade signal reports baoquankhu1.vn Mon, 23 Mar 2026 02:27:43 GMT
• pharma news: can allarity therapeutics inc expand its profit margins - 2026 bull vs bear & low volatility stock recommendations baoquankhu1.vn Sun, 22 Mar 2026 03:57:13 GMT
• allarity therapeutics, inc.: fundamental analysis and financial ratings | c6d | us0167441049 marketscreener.com Fri, 20 Mar 2026 06:43:30 GMT
• aug spikes: whats the analyst consensus on allarity therapeutics inc - global markets & ai driven stock reports baoquankhu1.vn Thu, 19 Mar 2026 20:16:40 GMT
• inflation data: can allarity therapeutics inc disrupt its industry - 2026 technicals & technical entry and exit tips baoquankhu1.vn Wed, 18 Mar 2026 12:20:05 GMT
Allarity Therapeutics, Inc.(NASDAQ:ALLR) 
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is i...
Website: https://www.allarity.com
Founded: 2004
Full Time Employees: 13
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends